Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults. [Phase 4]

View source ↗

Summary

A Phase 4 trial compares dolutegravir with darunavir/cobicistat in ART-naive adults with HIV to evaluate neuropsychiatric effects (insomnia and anxiety) over 12…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREZCOBIX (darunavir ethanolate and cobicistat)
  • Tivicay (dolutegravir)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: HIV, Insomnia | Phase 4 | Status: NOT_YET_RECRUITING